Advertisement

Topics

#news #biotech Tick saliva-based drug could lower heart disease risk in HIV patients

16:16 EDT 31 Aug 2017 | Biotech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Tick saliva-based drug could lower heart disease risk in HIV patients .HIV treatments have made enormous strides in recent decades, but patients—even those on antiretroviral drugs—have a higher … Continue reading

Cet article #news #biotech Tick saliva-based drug could lower heart disease risk in HIV patients est apparu en premier sur Biotech 365.

Original Article: #news #biotech Tick saliva-based drug could lower heart disease risk in HIV patients

NEXT ARTICLE

More From BioPortfolio on "#news #biotech Tick saliva-based drug could lower heart disease risk in HIV patients"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...